open access

Vol 89, No 6 (2018)
Research paper
Published online: 2018-06-29
Get Citation

The assessment of GWAS — identified polymorphisms associated with infertility risk in Polish women with endometriosis

Maciej Osiński1, Adrianna Mostowska2, Przemyslaw Wirstlein1, Ewa Wender-Ożegowska1, Paweł Piotr Jagodziński2, Małgorzata Szczepańska2
DOI: 10.5603/GP.a2018.0052
·
Pubmed: 30010178
·
Ginekol Pol 2018;89(6):304-310.
Affiliations
  1. Department of Obstetrics, Gynecology and Gynecological Oncology, Division of Reproduction University of Medical Sciences Karol Marcinkowski, 33 Polna St, 60-535 Poznań, Poland
  2. Department of Biochemistry and Molecular Biology University of Medical Sciences Karol Marcinkowski, 6 Święcickiego, 60-781 Poznań, Poland

open access

Vol 89, No 6 (2018)
ORIGINAL PAPERS Gynecology
Published online: 2018-06-29

Abstract

Objectives: Genome-wide association studies in patients with endometriosis revealed ten significant single nucleo­tide polymorphisms (SNPs) in the Caucasian population, which include rs12700667 near NFE2L3, rs12037376 in WNT4, rs7521902 near WNT4, rs13394619 in GREB1, rs10859871 near VEZT, rs1537377 near CDKN2B-AS1, rs4141819 near ETAA1, rs7739264 near ID4, rs1519761 near RND3 and rs6542095 near IL1A.

Material and methods: We replicated ten polymorphisms among infertile women with endometriosis (n = 315) and healthy fertile women (n = 406) in the Polish Caucasian population. Genotyping was conducted either by high-resolution melting curve analysis or by a pre-designed TaqMan probe.

Results: For all infertile women with endometriosis, the p values of the Cochran-Armitage trend test for the rs12700667 SNP was ptrend = 0.038 and the odds ratio (OR) for the risk allele frequency (RAF) of rs12700667 was 1.304 (95% CI = 1.009–1.685; p = 0.042). In patients with endometriosis with severity stages III/IV, ptrend for rs12700667 SNP was 0.036 and OR for the RAF was 1.394 (95% CI = 1.010–1.923; p = 0.043). In infertile women with endometriosis with severity stages III/IV for rs4141819 SNP, we observed ptrend = 0.026 and for RAF the OR = 1.350 (95% CI = 1.032–1.766; p = 0.029).

Conclusions: Our results demonstrate association of RAF of rs12700667 and rs4141819 SNPs with infertility in Polish women with advanced endometriosis.

Abstract

Objectives: Genome-wide association studies in patients with endometriosis revealed ten significant single nucleo­tide polymorphisms (SNPs) in the Caucasian population, which include rs12700667 near NFE2L3, rs12037376 in WNT4, rs7521902 near WNT4, rs13394619 in GREB1, rs10859871 near VEZT, rs1537377 near CDKN2B-AS1, rs4141819 near ETAA1, rs7739264 near ID4, rs1519761 near RND3 and rs6542095 near IL1A.

Material and methods: We replicated ten polymorphisms among infertile women with endometriosis (n = 315) and healthy fertile women (n = 406) in the Polish Caucasian population. Genotyping was conducted either by high-resolution melting curve analysis or by a pre-designed TaqMan probe.

Results: For all infertile women with endometriosis, the p values of the Cochran-Armitage trend test for the rs12700667 SNP was ptrend = 0.038 and the odds ratio (OR) for the risk allele frequency (RAF) of rs12700667 was 1.304 (95% CI = 1.009–1.685; p = 0.042). In patients with endometriosis with severity stages III/IV, ptrend for rs12700667 SNP was 0.036 and OR for the RAF was 1.394 (95% CI = 1.010–1.923; p = 0.043). In infertile women with endometriosis with severity stages III/IV for rs4141819 SNP, we observed ptrend = 0.026 and for RAF the OR = 1.350 (95% CI = 1.032–1.766; p = 0.029).

Conclusions: Our results demonstrate association of RAF of rs12700667 and rs4141819 SNPs with infertility in Polish women with advanced endometriosis.

Get Citation

Keywords

GWAS, endometriosis, infertility

About this article
Title

The assessment of GWAS — identified polymorphisms associated with infertility risk in Polish women with endometriosis

Journal

Ginekologia Polska

Issue

Vol 89, No 6 (2018)

Article type

Research paper

Pages

304-310

Published online

2018-06-29

DOI

10.5603/GP.a2018.0052

Pubmed

30010178

Bibliographic record

Ginekol Pol 2018;89(6):304-310.

Keywords

GWAS
endometriosis
infertility

Authors

Maciej Osiński
Adrianna Mostowska
Przemyslaw Wirstlein
Ewa Wender-Ożegowska
Paweł Piotr Jagodziński
Małgorzata Szczepańska

References (34)
  1. Wilczyński M, Wiecka-Płusa M, Antosiak B, et al. Rectovaginal endometriosis--analysis of 160 cases. Ginekol Pol. 2015; 86(12): 896–901.
  2. Bulun SE. Endometriosis. N Engl J Med. 2009; 360(3): 268–279.
  3. Luca A, Nemescu D, Butnaru M, et al. Ovarian stimulation outcome in infertile women with endometriosis undergoing IVF. Ginekol Pol. 2016; 87(1): 37–41.
  4. Davis AC, Goldberg JM. Extrapelvic Endometriosis. Semin Reprod Med. 2017; 35(1): 98–101.
  5. Borghese B, Zondervan KT, Abrao MS, et al. Recent insights on the genetics and epigenetics of endometriosis. Clin Genet. 2017; 91(2): 254–264.
  6. Jurkiewicz-Przondziono J, Lemm M, Kwiatkowska-Pamuła A, et al. Influence of diet on the risk of developing endometriosis. Ginekol Pol. 2017; 88(2): 96–102.
  7. Adachi S, Tajima A, Quan J, et al. Meta-analysis of genome-wide association scans for genetic susceptibility to endometriosis in Japanese population. J Hum Genet. 2010; 55(12): 816–821.
  8. Albertsen HM, Chettier R, Farrington P, et al. Genome-wide association study link novel loci to endometriosis. PLoS One. 2013; 8(3): e58257.
  9. Nyholt DR, Low SK, Anderson CA, et al. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet. 2012; 44(12): 1355–1359.
  10. Painter JN, Anderson CA, Nyholt DR, et al. Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet. 2011; 43(1): 51–54.
  11. Uno S, Zembutsu H, Hirasawa A, et al. A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet. 2010; 42(8): 707–710.
  12. Rahmioglu N, Nyholt DR, Morris AP, et al. Genetic variants underlying risk of endometriosis: insights from meta-analysis of eight genome-wide association and replication datasets. Hum Reprod Update. 2014; 20(5): 702–716.
  13. Sapkota Y, Fassbender A, Bowdler L, et al. Independent Replication and Meta-Analysis for Endometriosis Risk Loci. Twin Res Hum Genet. 2015; 18(5): 518–525.
  14. Canis M, Donnez JG, Guzick DS, et al. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67(5): 817–821.
  15. Szczepańska M, Wirstlein P, Skrzypczak J, et al. Polymorphic variants of CYP17 and CYP19A and risk of infertility in endometriosis. Acta Obstet Gynecol Scand. 2013; 92(10): 1188–1193.
  16. Saha R, Pettersson HJ, Svedberg P, et al. Heritability of endometriosis. Fertil Steril. 2015; 104(4): 947–952.
  17. Rahmioglu N, Montgomery GW, Zondervan KT. Genetics of endometriosis. Womens Health (Lond). 2015; 11(5): 577–586.
  18. Sapkota Y, Low SK, Attia J, et al. Association between endometriosis and the interleukin 1A (IL1A) locus. Hum Reprod. 2015; 30(1): 239–248.
  19. Li Y, Hao Na, Wang YX, et al. Association of Endometriosis-Associated Genetic Polymorphisms From Genome-Wide Association Studies With Ovarian Endometriosis in a Chinese Population. Reprod Sci. 2016 [Epub ahead of print].
  20. Borowski A, Dirksen U, Lixin L, et al. Structure and function of ETAA16: a novel cell surface antigen in Ewing's tumours. Cancer Immunol Immunother. 2006; 55(4): 363–374.
  21. Vainio S, Heikkilä M, Kispert A, et al. Female development in mammals is regulated by Wnt-4 signalling. Nature. 1999; 397(6718): 405–409.
  22. Rae JM, Johnson MD, Scheys JO, et al. GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res Treat. 2005; 92(2): 141–149.
  23. Pellegrini C, Gori I, Achtari C, et al. The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis. Fertil Steril. 2012; 98(5): 1200–1208.
  24. Miao R, Guo X, Zhi Q, et al. VEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer. PLoS One. 2013; 8(9): e74409.
  25. Pagliardini L, Gentilini D, Sanchez AM, et al. Replication and meta-analysis of previous genome-wide association studies confirm vezatin as the locus with the strongest evidence for association with endometriosis. Hum Reprod. 2015; 30(4): 987–993.
  26. Holdsworth-Carson SJ, Fung JN, Luong HTT, et al. Endometrial vezatin and its association with endometriosis risk. Hum Reprod. 2016; 31(5): 999–1013.
  27. Jarinova O, Stewart AFR, Roberts R, et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol. 2009; 29(10): 1671–1677.
  28. Liu Y, Sanoff HK, Cho H, et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One. 2009; 4(4): e5027.
  29. Pasmant E, Laurendeau I, Héron D, et al. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 2007; 67(8): 3963–3969.
  30. Goumenou AG, Arvanitis DA, Matalliotakis IM, et al. Loss of heterozygosity in adenomyosis on hMSH2, hMLH1, p16Ink4 and GALT loci. Int J Mol Med. 2000; 6(6): 667–671.
  31. Martini M, Ciccarone M, Garganese G, et al. Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis. Int J Cancer. 2002; 102(4): 398–406.
  32. Ren Y, Cheung HW, von Maltzhan G, et al. Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci Transl Med. 2012; 4(147): 147ra112.
  33. Verschuur-Maes AHJ, de Bruin PC, van Diest PJ. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer. Breast Cancer Res Treat. 2012; 136(3): 705–715.
  34. Miller JE, Ahn SH, Monsanto SP, et al. Implications of immune dysfunction on endometriosis associated infertility. Oncotarget. 2017; 8(4): 7138–7147.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl